345 related articles for article (PubMed ID: 11213831)
41. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
42. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
43. Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma.
Leung SY; Chan AS; Wong MP; Yuen ST; Cheung N; Chung LP
Am J Surg Pathol; 1997 Aug; 21(8):941-50. PubMed ID: 9255258
[TBL] [Abstract][Full Text] [Related]
44. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
[TBL] [Abstract][Full Text] [Related]
45. Expression of vascular endothelial growth factor (VEGF) and its receptors during embryonic implantation in the golden hamster (Mesocricetus auratus).
Yi XJ; Jiang HY; Lee KK; O WS; Tang PL; Chow PH
Cell Tissue Res; 1999 May; 296(2):339-49. PubMed ID: 10382276
[TBL] [Abstract][Full Text] [Related]
46. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
Ozaki NK; Beharry KD; Nishihara KC; Akmal Y; Ang JG; Sheikh R; Modanlou HD
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
[TBL] [Abstract][Full Text] [Related]
47. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
48. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes.
Bogic LV; Brace RA; Cheung CY
Placenta; 2001 Apr; 22(4):265-75. PubMed ID: 11286562
[TBL] [Abstract][Full Text] [Related]
49. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
50. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.
Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S
Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732
[TBL] [Abstract][Full Text] [Related]
51. Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization.
Wada M; Ogata N; Otsuji T; Uyama M
Curr Eye Res; 1999 Mar; 18(3):203-13. PubMed ID: 10342375
[TBL] [Abstract][Full Text] [Related]
52. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
Li J; Brown LF; Hibberd MG; Grossman JD; Morgan JP; Simons M
Am J Physiol; 1996 May; 270(5 Pt 2):H1803-11. PubMed ID: 8928889
[TBL] [Abstract][Full Text] [Related]
53. Expression of vascular endothelial growth factor and its receptors during lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in rats.
Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Sakitani H; Iki K; Taniguchi S; Kitamura S; Konishi Y
Mol Carcinog; 1999 Apr; 24(4):287-93. PubMed ID: 10326865
[TBL] [Abstract][Full Text] [Related]
54. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
Donnini S; Machein MR; Plate KH; Weich HA
J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
[TBL] [Abstract][Full Text] [Related]
55. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
[TBL] [Abstract][Full Text] [Related]
56. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
Brown LF; Detmar M; Tognazzi K; Abu-Jawdeh G; Iruela-Arispe ML
Lab Invest; 1997 Feb; 76(2):245-55. PubMed ID: 9042161
[TBL] [Abstract][Full Text] [Related]
57. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
58. [Correlation of neovascularization and vascular endothelial growth factor in human renal cell carcinoma].
Sato K; Kato T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):389-94. PubMed ID: 9063473
[TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial growth factor-C (VEGF-C) and its receptors KDR and flt-4 are expressed in AIDS-associated Kaposi's sarcoma.
Skobe M; Brown LF; Tognazzi K; Ganju RK; Dezube BJ; Alitalo K; Detmar M
J Invest Dermatol; 1999 Dec; 113(6):1047-53. PubMed ID: 10594750
[TBL] [Abstract][Full Text] [Related]
60. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.
Masood R; Cai J; Zheng T; Smith DL; Naidu Y; Gill PS
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):979-84. PubMed ID: 9023368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
